By Alexander Bueso
Date: Monday 14 Sep 2020
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
No recent information was found.
Currency | Euro |
Share Price | 290.00 |
Change Today | 7.00 |
% Change | 2.47 % |
52 Week High | 330.00 |
52 Week Low | 184.20 |
Volume | 51,860 |
Shares Issued | 8.35m |
Market Cap | 2,421.12m |
Beta | 0.54 |
Time | Volume / Share Price |
17:37 | 15 @ 290.00 |
17:37 | 114 @ 290.00 |
17:37 | 223 @ 290.00 |
17:37 | 4 @ 290.00 |
17:35 | 8 @ 290.00 |
You are here: research